HUTT to Assess Cardiac Autonomic Nervous Function
ConditionAutonomic Nervous System Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-85
SponsorThe First Hospital of Hebei Medical University
About this trial
Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Vertical tilt test and 24-hour holter electrocardiogram were performed at the same time
Receive treatment in our hospital.
Disqualifiers
Taking benzodiazepines or hypotensive drugs within 24 hours
Combined with mental illness, severe dementia, serious organ disease
Severe arrhythmia, deep breathing and poor coordination of Valsaval movements affected the interpretation of results.
Trial population
A total of 1122 (546 males, 576 females) samples were collected according to the inclusion and exclusion criteria.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
To find the indicators which are most correlated to the sympathetic and vagus nerves.
The investigators use HUTT and CASS score to find some indicators which are most correlated to the sympathetic and vagus nerves,so that can give data support to the clinical treatments
Time frame
February 13, 2023 to December 31, 2025Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov